| |
| |
|
| Insider
Information: |
Lippoldt Darin |
| Relationship: |
Chief Legal Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
44,535 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,540,948 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
44,535 |
|
|
| Total
Value |
$5,540,948 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Volcano Corp |
VOLC |
EVP, General Counsel |
2014-03-19 |
4,795 |
2012-02-15 |
0 |
Premium* |
|
|
Neurocrine Biosciences Inc |
NBIX |
Chief Legal Officer |
2024-02-13 |
39,740 |
2015-11-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2021-02-09 |
4 |
OE |
$35.99 |
$1,302,622 |
D/D |
36,194 |
40,369 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2021-02-09 |
4 |
AS |
$116.16 |
$4,204,831 |
D/D |
(36,194) |
34,361 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2015-11-09 |
4 |
OE |
$18.15 |
$431,262 |
D/D |
23,761 |
23,761 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2015-11-09 |
4 |
AS |
$52.92 |
$1,257,432 |
D/D |
(23,761) |
0 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2023-12-06 |
4 |
OE |
$43.24 |
$900,689 |
D/D |
20,830 |
56,712 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2023-12-06 |
4 |
AS |
$119.86 |
$2,496,648 |
D/D |
(20,830) |
35,882 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2019-07-30 |
4 |
OE |
$18.15 |
$287,333 |
D/D |
15,831 |
35,792 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2019-07-30 |
4 |
AS |
$92.13 |
$1,458,569 |
D/D |
(15,831) |
19,961 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2017-12-28 |
4 |
OE |
$18.15 |
$276,552 |
D/D |
15,237 |
28,394 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2017-12-28 |
4 |
AS |
$75.00 |
$1,142,775 |
D/D |
(15,237) |
13,157 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2023-02-07 |
4 |
AS |
$102.24 |
$1,466,680 |
D/D |
(14,323) |
44,157 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2017-04-12 |
4 |
AS |
$50.41 |
$658,774 |
D/D |
(13,065) |
13,157 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2023-11-27 |
4 |
AS |
$112.27 |
$1,225,911 |
D/D |
(10,919) |
35,882 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2017-05-18 |
4 |
OE |
$18.15 |
$181,500 |
D/D |
10,000 |
23,157 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2017-05-18 |
4 |
AS |
$53.27 |
$532,700 |
D/D |
(10,000) |
13,157 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2019-11-08 |
4 |
OE |
$32.99 |
$329,900 |
D/D |
10,000 |
23,478 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2019-11-08 |
4 |
AS |
$110.00 |
$1,100,057 |
D/D |
(10,000) |
20,103 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2022-10-04 |
4 |
AS |
$111.04 |
$1,110,446 |
D/D |
(10,000) |
29,234 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2022-10-04 |
4 |
OE |
$43.24 |
$432,400 |
D/D |
10,000 |
39,234 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2022-11-01 |
4 |
AS |
$120.09 |
$1,200,899 |
D/D |
(10,000) |
29,234 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2022-11-01 |
4 |
OE |
$43.24 |
$432,400 |
D/D |
10,000 |
39,234 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2024-01-22 |
4 |
AS |
$139.86 |
$1,398,553 |
D/D |
(10,000) |
35,882 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2024-01-22 |
4 |
OE |
$79.02 |
$790,200 |
D/D |
10,000 |
45,882 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2017-11-15 |
4 |
AS |
$73.05 |
$723,191 |
D/D |
(9,900) |
13,157 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Legal Officer |
• – – |
2017-11-15 |
4 |
OE |
$18.15 |
$179,685 |
D/D |
9,900 |
23,057 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
